Эплеренон в лечении хронической болезни почек при сопутствующей артериальной гипертензии [PDF]
Литературный обзор посвящен месту селективных блокаторов альдостерона в лечении хронической болезни почек при сопутствующей артериальной ...
Авдеева, И. В. +3 more
core +1 more source
56 The impact of statin therapy on the efficacy of eplerenone [PDF]
Harvey D. White +6 more
openalex +1 more source
#4590 A PROSPECTIVE STUDY OF EPLERENONE IN THE TREATMENT OF PATIENTS WITH GLOMERULONEPHRITIS [PDF]
Marios Papasotiriou +5 more
openalex +1 more source
Eplerenone in chronic renal disease: the EVALUATE trial [PDF]
John W. Funder
openalex +1 more source
Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity [PDF]
Received 22 July 2012; revised 29 January 2013; accepted 4 March 2013Aims Aldosterone plays a crucial role in cardiovascular disease. ‘Systemic' inhibition of its mineralocorticoid receptor (MR) decreases atherosclerosis by reducing inflammation and ...
Berger, Stefan +11 more
core
Positive effect of eplerenone treatment on endothelial progenitor cells in patients with chronic heart failure [PDF]
Christian Jung +11 more
openalex +1 more source
Crossover to Half-Dose Photodynamic Therapy or Eplerenone in Chronic Central Serous Chorioretinopathy Patients [PDF]
Helena M. A. Feenstra +7 more
openalex +1 more source
Formulation and Characterization of Eplerenone Nanoemulsion Liquisolids, An Oral Delivery System with Higher Release Rate and Improved Bioavailability [PDF]
Ahmed Khames
openalex +1 more source
Kostas Athanasakis,1 Aikaterini Bilitou,2 Dawn Lee,3 Eleftheria Karampli,1 Apostolos Karavidas,4 John Parissis,5 Georgia Sykara,2 John Kyriopoulos1 1Department of Health Economics, National School of Public Health, Athens, Greece; 2Pfizer Hellas, Athens,
Athanasakis K +7 more
doaj
Bart, Bradley A., Nelson, Sarah
openaire +1 more source

